These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23300042)

  • 41. Usefulness of diffusion-tensor MRI in the diagnosis of Parkinson variant of multiple system atrophy and Parkinson's disease: a valuable tool to differentiate between them?
    Chen B; Fan G; Sun W; Shang X; Shi S; Wang S; Lv G; Wu C
    Clin Radiol; 2017 Jul; 72(7):610.e9-610.e15. PubMed ID: 28318507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
    Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
    Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Kremser C; Wildauer M; Schocke M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    J Parkinsons Dis; 2019; 9(4):681-691. PubMed ID: 31450511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.
    Barbagallo G; Sierra-Peña M; Nemmi F; Traon AP; Meissner WG; Rascol O; Péran P
    Mov Disord; 2016 Mar; 31(3):325-34. PubMed ID: 26676922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
    Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
    Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.
    Hope TR; Selnes P; Rektorová I; Anderkova L; Nemcova-Elfmarkova N; Balážová Z; Dale A; Bjørnerud A; Fladby T
    PLoS One; 2019; 14(5):e0217922. PubMed ID: 31150514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study.
    Worker A; Blain C; Jarosz J; Chaudhuri KR; Barker GJ; Williams SC; Brown RG; Leigh PN; Dell'Acqua F; Simmons A
    PLoS One; 2014; 9(11):e112638. PubMed ID: 25405990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Differentiation of atypical Parkinson syndrome and delineation from idiopathic Parkinson syndrome with routine magnetic resonance tomography].
    Csoti I; Warmuth-Metz M; Solymosi L; Becker Dagger G; Fornadi F; Naumann M
    Nervenarzt; 2004 Feb; 75(2):128-34. PubMed ID: 14770282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Degeneration of ponto-cerebellar tract visualized by diffusion tensor imaging in multiple system atrophy].
    Fujimori J; Tatewaki Y; Shimizu H; Kimura I; Hisanaga K
    Rinsho Shinkeigaku; 2011 Apr; 51(4):271-4. PubMed ID: 21595297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Case control study of diffusion tensor imaging in Parkinson's disease.
    Chan LL; Rumpel H; Yap K; Lee E; Loo HV; Ho GL; Fook-Chong S; Yuen Y; Tan EK
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1383-6. PubMed ID: 17615165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffusion tensor imaging-based pontine damage as a degeneration marker in synucleinopathy.
    Chung SJ; Cho KH; Lee YH; Yoo HS; Baik K; Jung JH; Ye BS; Sohn YH; Cha J; Lee PH
    J Neurosci Res; 2021 Nov; 99(11):2922-2931. PubMed ID: 34521154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of diffusion tensor imaging to identify similarities and differences between cerebellar and Parkinsonism forms of multiple system atrophy.
    Wang PS; Wu HM; Lin CP; Soong BW
    Neuroradiology; 2011 Jul; 53(7):471-81. PubMed ID: 20737142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease.
    Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
    Mov Disord; 2007 Dec; 22(16):2352-8. PubMed ID: 17894342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The value of GRE, ADC and routine MRI in distinguishing Parkinsonian disorders.
    Wadia PM; Howard P; Ribeirro MQ; Robblee J; Asante A; Mikulis DJ; Lang AE
    Can J Neurol Sci; 2013 May; 40(3):389-402. PubMed ID: 23603177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuromelanin magnetic resonance imaging in Parkinson's disease and multiple system atrophy.
    Matsuura K; Maeda M; Yata K; Ichiba Y; Yamaguchi T; Kanamaru K; Tomimoto H
    Eur Neurol; 2013; 70(1-2):70-7. PubMed ID: 23796701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toward More Accessible Fully Automated 3D Volumetric MRI Decision Trees for the Differential Diagnosis of Multiple System Atrophy, Related Disorders, and Age-Matched Healthy Subjects.
    Kim J; Young GS; Willett AS; Pitaro AT; Crotty GF; Mesidor M; Jones KA; Bay C; Zhang M; Feany MB; Xu X; Qin L; Khurana V
    Cerebellum; 2023 Dec; 22(6):1098-1108. PubMed ID: 36156185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diffusion tensor imaging parameters' changes of cerebellar hemispheres in Parkinson's disease.
    Mormina E; Arrigo A; Calamuneri A; Granata F; Quartarone A; Ghilardi MF; Inglese M; Di Rocco A; Milardi D; Anastasi GP; Gaeta M
    Neuroradiology; 2015 Mar; 57(3):327-34. PubMed ID: 25479963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced fractional anisotropy in early-stage cerebellar variant of multiple system atrophy.
    Oishi K; Konishi J; Mori S; Ishihara H; Kawamitsu H; Fujii M; Kanda F
    J Neuroimaging; 2009 Apr; 19(2):127-31. PubMed ID: 18498329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffusion tensor imaging in idiopathic Parkinson's disease and multisystem atrophy (Parkinsonian type).
    Cnyrim CD; Kupsch A; Ebersbach G; Hoffmann KT
    Neurodegener Dis; 2014; 13(1):1-8. PubMed ID: 23711586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.